Asia Pacific Consortium of Veterinary Epidemiology Phase 2 (APCOVE II)

The Asia Pacific Consortium of Veterinary Epidemiology (APCOVE) was established in 2020 to build veterinary epidemiology capacity across the Asia Pacific region. Led by the University of Sydney, APCOVE brings together over 50 animal health experts from all veterinary schools in Australia and New Zealand, and eight partner countries: Cambodia, Laos, Indonesia, Malaysia, Papua New Guinea, the Philippines, Timor-Leste, and Vietnam.

The Sydney Asia-Pacific Partnership for Health Innovations and Resilient Ecosystems (SAPPHIRE)

Australia is supporting the second phase of the Sydney Asia-Pacific Partnership for Health Innovations and Resilient Ecosystems (SAPPHIRE) to expand beyond Fiji, Kiribati and Vietnam and into Cambodia. In partnership with the University of Sydney, SAPPHIRE emphasises community participation, infectious and chronic disease control, health system strengthening, One Health adoption, climate change adaptation, and GEDSI integration for regional health security.

Regional Engagement in Surveillance and response to Priority diseases, providing Opportunities for National health system strengthening and Development (RESPOND)

Australia is supporting partner countries to build capacity for health systems to anticipate, prevent, detect and control priority disease threats through the Regional Engagement in Surveillance and response to Priority diseases, providing Opportunities for National health system strengthening and Development (RESPOND) partnership with Menzies School of Health Research. 

Doherty Institute Strategic Partnership for prevention, surveillance and response to infectious diseases across the Indo-Pacific Region

Australia is strengthening its commitment to the prevention, surveillance and response to infectious diseases across the Indo-Pacific through a strategic partnership with the Doherty Institute. Over the next four years, our partnership will focus on workforce development, policy support, and systems strengthening, and will specifically target laboratory strengthening, genomic surveillance, antimicrobial resistance (AMR), and data for decision making.